Rise Therapeutics
PrivateLast Round
Grant
Dec 15, 2025
Total Funding Raised
$4.78M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rise Therapeutics is a biotechnology company that develops synthetic biology-based oral immunotherapies for the treatment of autoimmune diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rise Therapeutics Comparables
Compare Rise Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sorriso Therapeutics | 78% | |
| Enterome | 76% | |
| Rani Therapeutics | 73% | |
Rise Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 15, 2025 | ||||
| Grant | Oct 22, 2025 | ||||
| Grant | Sep 23, 2025 | ||||
| Grant | Oct 22, 2024 | ||||
| Grant | Sep 4, 2023 | ||||
Seed | May 8, 2023 |
Rise Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| TEDCO | Grant, Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| National Institute of Dental and Craniofacial Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2025
$998K grant received from TEDCO.
- Oct 22, 2024
Received grant funding from NIDDK and NIH RADx.
Rise Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rise Therapeutics's valuation, stock price, and market status.